Tobacco Use Cessation Clinical Trial
— PROMOTE-UPOfficial title:
Comparative Effectiveness of Mobile Health Smoking Cessation Approaches Among Underserved Patients in Primary Care
This study will evaluate the comparative effectiveness of three smoking cessation therapies: mobile health (mHealth) application iCanQuit, mHealth application iCanQuit + Motiv8, and the Florida quit line.
Status | Recruiting |
Enrollment | 1332 |
Est. completion date | December 31, 2026 |
Est. primary completion date | June 30, 2026 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 21 Years and older |
Eligibility | Inclusion Criteria: - =21 years old - Referred by the provider via Ask-Advise-Connect - Receiving care at one of the participating clinics - Daily access to their own smart phone (the study team will provide assistance to patients without a phone to obtain one through aid programs for low-income patients) - No household members already enrolled Exclusion Criteria: - Unstable medical or psychiatric illness |
Country | Name | City | State |
---|---|---|---|
United States | University of Florida | Gainesville | Florida |
Lead Sponsor | Collaborator |
---|---|
University of Florida | Patient-Centered Outcomes Research Institute |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Smoking Point-Prevalence Abstinence (PPA) | negative CO breath sample = 5 ppm using an iCO monitor, and self-reported abstinence from smoking in the last 7 days | Month 6 | |
Secondary | Smoking Point-Prevalence Abstinence (PPA) | negative CO breath sample = 5 ppm using an iCO monitor, and self-reported abstinence from smoking in the last 7 days | Months 2 and 12 | |
Secondary | Treatment Satisfaction | 5-item scale measuring treatment by interest, usefulness, concern with privacy, how easy to understand, and satisfaction. Items will be measured on a 0-10 point scale, with higher scores corresponding to greater acceptability. | Month 12 | |
Secondary | Quality of Life and Well-Being | World Health Organization Quality of Life-BREF (WHOQOL-BREF): 26-item scale that measures quality of life. Items are rated on a 5-point Likert scale (low score of 1 to high score of 5), with a higher score indicating a higher quality of life. | Baseline, and month 6 | |
Secondary | Self Efficacy | Self-Efficacy Questionnaire (SEQ-12): 12-item scale. Items are rated on a 5-point Likert scale (low score of 1 to high score of 5), with higher scores indicating greater self-efficacy. | Baseline, and month 6 | |
Secondary | Acceptance | 9-item physical sensations subscale of the Avoidance and Inflexibility Scale. Items are rated on a 5-point Likert scale (low score of 1 to high score of 5), with higher scores reflecting more inflexibility/avoidance in the presence of difficult smoking-related thoughts, feelings, and sensations. | Months 2 and 6 | |
Secondary | Values | Valuing Questionnaire (VQ): 10-item measure assessing the extent to which one lives consistently with their values, including Progress and Obstruction subscales. Both subscales total scores range from 0 to 30. A psychologically healthier score is indicated by a higher score on the Progress scale along with a lower score on the Obstructions scale. | Months 2 and 6 | |
Secondary | Motivation | Motivational Engagement Questionnaire: 5-item measure. Items are rated on a 7-point Likert scale (low score of 1 to high score of 7), with higher scores indicating more motivation to quit smoking. | Months 2 and 6 | |
Secondary | Smoking Prolonged Abstinence | Self-reported abstinence from the date of the last time a cigarette was smoked. | Months 6 and 12 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT06021652 -
Feasibility, Adoption and Efficacy of A Virtual Reality Smoking Cessation Program for Patients Undergoing Lung Cancer Screening
|
N/A | |
Completed |
NCT02735382 -
EHR-Based and Fax-Based Referral to a Tobacco Quitline: A Comparative Study
|
N/A | |
Completed |
NCT02557919 -
Families Reduce Exposure to Smoke at Home
|
N/A | |
Completed |
NCT01570595 -
Positively Smoke Free on the Web (PSFW) for Smokers Living With HIV
|
Phase 1/Phase 2 | |
Completed |
NCT00786149 -
Improving Varenicline Adherence and Outcomes in Homeless Smokers
|
Phase 3 | |
Completed |
NCT00387946 -
Efficacy and Safety of Dianicline Treatment as an Aid to Smoking Cessation in Cigarette Smokers (AMERIDIAN)
|
Phase 3 | |
Completed |
NCT00218452 -
Smoking Cessation for Young Adults Who Binge Drink - 1
|
Phase 0 | |
Completed |
NCT00124683 -
Treating Nicotine Dependence in Schizophrenic Individuals: Effectiveness of Bupropion - 1
|
Phase 2 | |
Recruiting |
NCT04610931 -
Study of the Effectiveness of a Virtual Reality Treatment in the Management of Smoking Cessation
|
N/A | |
Enrolling by invitation |
NCT06042361 -
Enhancing Equity in Smoke-free Housing
|
N/A | |
Recruiting |
NCT04827420 -
Mi QUIT CARE (Mile Square QUIT Community-Access-Referral-Expansion)
|
N/A | |
Recruiting |
NCT04994444 -
Preloading With Nicotine Replacement Therapy in HIV-positive Smokers to Improve Self-Efficacy and Quit Attempts
|
Phase 2/Phase 3 | |
Completed |
NCT05560243 -
Tobacco Cessation Tailored to Patients Living With HIV (PLWH) in Brazil
|
N/A | |
Completed |
NCT02721082 -
Changing the Default for Tobacco Treatment
|
Phase 4 | |
Completed |
NCT01885221 -
A Multi-Media Approach to Partner Support in Smokeless Tobacco Cessation (UCare-ChewFree)
|
N/A | |
Completed |
NCT03445507 -
Effectiveness of a Chat Bot for Smoking Cessation: a Pragmatic Trial in Primary Care.
|
N/A | |
Completed |
NCT04540081 -
Enhancing Electronic Health Systems to Decrease the Burden of Colon Cancer, Lung Cancer, Obesity, Vaccine-Preventable Illness, and LivER Cancer
|
N/A | |
Completed |
NCT03714191 -
Optimizing the Tobacco Cessation Clinical Decision Support Tool.
|
||
Completed |
NCT03553992 -
An Extended Facebook Intervention for Young Sexual and Gender Minority Smokers
|
N/A | |
Completed |
NCT01699828 -
Exploring Occupancy of Dopamine D3 Receptor by Buspirone in Humans Using PET
|
Phase 1/Phase 2 |